Home > News > Pharmaceutical News
Posted on Nov 20, 10:14PM | IANS
Drug-maker Lupin Tuesday said its subsidiary Lupin Pharmaceuticals Inc has launched cholesterol lowering drug Fenofibrate tablets in 48mg and 145mg strengths in the United States.
The Mumbai-based company's Fenofibrate tablets are a generic version of Abbott's Tricor tablets.
Lupin had received US Food and Drug Administration approval for the drug earlier.
"We are very happy to bring this product to market in the United States. Patients can be assured that they are receiving the same high quality product they have been accustomed to at a more affordable price," Vinita Gupta, Lupin group president, said in a statement.